VIRUS-ASSOCIATED AND VIRUS-NEGATIVE CERVICAL CARCINOMA: CLINICAL FEATURES
https://doi.org/10.51523/2708-6011.2010-7-1s-23
Abstract
To determine the presence of HPV oncotropic types, 78 patients with cervical carcinoma, attending the Scientific Research Centre of Oncology, have been examined. Among the examined patients, 90% were diagnosed as positive for genital HPV infection. The study reveals, that the patients with virus-associated cervical carcinoma have more commonly early stages of the disease, in locally invasive cervical carcinoma high virus load becomes more pronounced, and a more favorable course of the disease in comparison with virus-negative cervical carcinoma takes place.
About the Authors
O. N. Churksaeva
Scientific Research Centre of Oncology of the Siberian Department of the Russian Academy of Medical Sciences
Belarus
Belarus
L. A. Kolomiets
Scientific Research Centre of Oncology of the Siberian Department of the Russian Academy of Medical Sciences
Belarus
Belarus
I. G. Vidyaeva
Scientific Research Centre of Oncology of the Siberian Department of the Russian Academy of Medical Sciences
Belarus
Belarus
L. N. Urazova
Scientific Research Centre of Oncology of the Siberian Department of the Russian Academy of Medical Sciences
Belarus
Belarus
E. G. Nikitina
Scientific Research Centre of Oncology of the Siberian Department of the Russian Academy of Medical Sciences
Belarus
Belarus
References
1. Давыдов, М. И. Заболеваемость злокачественными новообразованиями / М. И. Давыдов, Е. М. Аксель // Вестн. РАМН. - 2007. - Т. 18, № 2. - С. 52-89.
2. ВПЧ-отрицательный рак шейки матки и его прогноз / В. И. Киселева [и др.] // Российский онкологический журнал. - 2008. - № 3. - С. 23-26.
3. Bohmer, G. [et al.] // Am. J. Obstet. Gynecol. - 2003. - Vol. 189. - P. 118-120.
4. Datta, N. [et al.] // Gynecol. Oncol. - 2006. - Vol. 103, № 1. - P. 100-105.
5. IARC WHU Press Release 151 IARC confirms efficacy of cervix cancer screening for women 25-65 in reducing mortality, 03 May 2004.
6. Harima, Y. [et al.] // Int. J. Radiat. Oncol. Biol. Phys. - 2002. - Vol. 52. - P. 1345-1351.
7. A controlled trial of a human papillomavirus type 16 vaccine / L. Koutsky [et al.] // N. Engl. J. Med. - 2002. - № 347. - Р. 1645-1651.
8. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma / M. Moberg [et al.] // Br. J. Cancer. - 2005. - № 92. - Р. 891-894.
9. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associatedwith cervical cancer / N. Munoz [et al.] // N. Engl. J. Med. - 2003. - Vol. 6, № 348. - Р. 518-527.
10. Parkin D. M. The burden of HPV-related cancers / D. M. Parkin, F. Bray // Vaccine. - 2006. - Vol. 24, № 3. - Р. 11-25.
11. Zur Hausen, H. // Ed. H.zur Hausen // Human pathogenic papillomaviruses, topics in microbiology and immunology. - 1994. - Vol. 186. - P. 131-157.
Review
For citations:
Churksaeva O.N., Kolomiets L.A., Vidyaeva I.G., Urazova L.N., Nikitina E.G. VIRUS-ASSOCIATED AND VIRUS-NEGATIVE CERVICAL CARCINOMA: CLINICAL FEATURES. Health and Ecology Issues. 2010;(1S):62-64. (In Russ.) https://doi.org/10.51523/2708-6011.2010-7-1s-23
Views: 266
Email this article 